Arizona State Retirement System - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
Arizona State Retirement System ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$70,658
-32.8%
16,356
+2.5%
0.00%0.0%
Q2 2023$105,111
-5.6%
15,950
-2.7%
0.00%0.0%
Q1 2023$111,336
-5.6%
16,397
+2.7%
0.00%0.0%
Q4 2022$117,944
-22.4%
15,960
+4.0%
0.00%
-50.0%
Q3 2022$152,000
-7.9%
15,351
+1.3%
0.00%0.0%
Q2 2022$165,000
-2.9%
15,151
+0.6%
0.00%
+100.0%
Q1 2022$170,000
-27.7%
15,060
+0.6%
0.00%
-50.0%
Q4 2021$235,000
-9.3%
14,975
-1.1%
0.00%0.0%
Q3 2021$259,000
-19.3%
15,135
+1.4%
0.00%
-33.3%
Q2 2021$321,000
+34.3%
14,919
-6.3%
0.00%
+50.0%
Q1 2021$239,000
+14.9%
15,921
+0.5%
0.00%0.0%
Q4 2020$208,000
+30.8%
15,838
-3.8%
0.00%0.0%
Q3 2020$159,000
+14.4%
16,460
+35.9%
0.00%0.0%
Q2 2020$139,000
+18.8%
12,109
+7.4%
0.00%0.0%
Q1 2020$117,000
-80.0%
11,270
-68.3%
0.00%
-71.4%
Q4 2019$584,000
-29.7%
35,567
-43.2%
0.01%
-30.0%
Q3 2019$831,000
-28.2%
62,569
-23.8%
0.01%
-23.1%
Q2 2019$1,158,000
-22.5%
82,158
+1.2%
0.01%
-27.8%
Q1 2019$1,494,000
-29.2%
81,209
+0.5%
0.02%
-33.3%
Q4 2018$2,111,000
-29.3%
80,772
-37.9%
0.03%
-3.6%
Q3 2018$2,984,000130,0000.03%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,525,476$74,263,0004.09%
ARMISTICE CAPITAL, LLC 2,828,000$46,407,0002.68%
Birchview Capital, LP 80,000$1,313,0000.95%
GLOBEFLEX CAPITAL L P 145,426$2,386,0000.45%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 231,733$3,803,0000.36%
361 CAPITAL LLC 77,630$1,274,0000.35%
CADENCE CAPITAL MANAGEMENT LLC 152,428$2,501,0000.27%
BOOTHBAY FUND MANAGEMENT, LLC 148,000$2,429,0000.21%
EMERALD ADVISERS, LLC 258,497$4,242,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 251,730$4,131,0000.17%
View complete list of VANDA PHARMACEUTICALS INC shareholders